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Abstract 
Although several efficacious treatments for Posttraumatic Stress Disorder (PTSD) exist, these 
treatments are currently underutilized in clinical practice. To address this issue, research must 
better identify barriers to dissemination of these treatments.  This study investigated patient 
preferences for PTSD treatment given a wide range of treatment options in an analogue 
sample. One hundred and sixty individuals, with varying degrees of trauma history, were asked 
to imagine themselves undergoing a trauma, developing PTSD, and seeking treatment.  
Participants evaluated seven different treatment descriptions which depicted treatment options 
that they might encounter in a clinical setting.  Participants rated their most and least preferred 
treatments along with their personal reactions to and the perceived credibility of each treatment.   
Participants also completed a critical thinking skills questionnaire.  Participants predominantly 
chose exposure or another variant of cognitive-behavioral therapy as their most preferred 
therapy, and those who chose exclusively empirically supported treatments evidenced higher 
critical thinking skills. The present study contributes to a growing literature indicating that 
patients may be more interested in these therapies than indicated by utilization rates. The 
problem of underutilization of empirically supported treatments for PTSD in clinical practice may 
be due to therapist factors.   
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An Analogue Study of Patient Preferences for Exposure versus Alternative Treatments for Post 
Traumatic Stress Disorder 
1.1 Introduction 
Strong empirical support exists for the use of exposure to treat posttraumatic stress 
disorder (PTSD: Foa, Keane, & Friedman, 2000).  Despite this, research suggests that 
exposure remains underutilized in clinical practice (Becker, Zayfert, & Anderson, 2004; Foy et 
al., 1996; Rosen et al., 2004). For example, Becker et al. found that 83% of 207 licensed 
psychologists reported not using imaginal exposure to treat PTSD. Even among those who had 
been formally trained in exposure for PTSD (n = 59), 46% reported treating none of their 
patients with imaginal exposure, and only 15% reported routine use of exposure. Rosen et al. 
similarly found that less than 20% of PTSD experts in a VA setting reported routine use of 
exposure to treat PTSD. 
Clinical underutilization of empirically supported treatments (EST), such as exposure, 
may result from therapist factors (e.g., lack of training, perceptions about the treatment), patient 
factors (e.g., credibility of treatment rationale, anticipation of discomfort), or an interaction of the 
two. An interaction might involve a patient expressing concern about an EST and a therapist, 
who is also uncomfortable with the EST, using the patient’s concern to justify choosing an 
alternate treatment instead of reviewing the rationale or exploring the patient’s concerns. 
Although limited, research exploring therapist factors and use of exposure for PTSD 
currently highlights the role therapists may play in underutilization. For example, almost three 
quarters of the psychologists in Becker et al. (2004) reported that lack of training influenced their 
non-use of exposure. They also reported a high rate of perceived contraindications to exposure 
and concerns about complications resulting from use of exposure. Similarly, Najavits (2006) 
found that, compared to a present focused skills based intervention, clinician participants at a 
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workshop on the treatment of PTSD and substance use disorders rated an exposure-based 
intervention as significantly less appealing to conduct. The clinicians also rated exposure as 
less important for dual diagnosed PTSD patients and less safe in a group format, in an 
individual format, and when conducted as a short-term intervention (e.g., four months or less). 
In addition, participants endorsed greater concerns about exposure requiring specialized 
training. Taken together, results suggest that both lack of training and clinical concerns about 
exposure for PTSD may decrease therapists’ use. 
The limited research exploring patient factors, however, has produced differing results. 
For example, Zoellner, Feeny, Cochran, and Pruitt (2003) conducted an analogue study 
exploring patient preference for exposure versus medication. Female students with varying 
degrees of trauma history read a description of a traumatic event and subsequently indicated 
what they would do if they experienced that event. Given a forced choice of exposure, 
sertraline, or no treatment, participants overwhelmingly chose exposure. Exposure also was 
rated as more credible and produced more positive personal reactions. Results of this analogue 
study subsequently were largely replicated in a patient population (Feeny & Zoellner, 2004). The 
findings of this second study provide some support for the initial analogue approach. 
Although the Zoellner et al. (2003) and Feeny & Zoellner (2004) studies provide 
preliminary evidence that patients may have fewer concerns about exposure for PTSD as 
compared to therapists, the forced choice results also can be interpreted as indicating that 
patients prefer psychotherapy over medication. Thus, these studies do not indicate the degree 
to which patients might select exposure as the treatment of choice when offered a range of 
psychotherapy options.  
In an online analogue survey, Tarrier, Liversidge, and Gregg (2006) evaluated potential 
patient attitudes to a range of psychological PTSD interventions. Students rated 14 
psychological treatments on a variety of scales and then ranked these treatments from most to 
least preferred. Tarrier et al. selected their interventions based on the PTSD treatment literature. 
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The interventions included: psycho-education, imaginal exposure, in vivo exposure, virtual 
reality exposure, guided imagery, cognitive therapy, cognitive therapy plus exposure, stress 
management, eye movement desensitization and reprocessing therapy (EMDR), computer 
based treatment including exposure and stress management, psychodynamic therapy, E-
therapy conducted with a therapist over the internet, group therapy including exposure and 
stress management, and family therapy including problem solving. Cognitive therapy emerged 
as the therapy of choice; treatments involving exposure also were highly ranked (i.e., included in 
three of the five top ranked treatments) despite receiving high ratings on a scale assessing 
projected discomfort. All of the five highest ranking treatments in this study were presented as 
efficacious, suggesting that analogue patients seem attuned to treatment efficacy and appear 
willing to tolerate discomfort when deciding to enroll in a particular therapy. Interestingly, EMDR, 
which has some significant empirical support and appears popular among therapists, received 
some of the lowest ratings, suggesting that patients also may consider factors other than 
efficacy.  
 The results of Tarrier et al. (2006) support those found by Zoellner et al. (2003) and 
Feeny and Zoellner (2004), and suggest that exposure for PTSD may be of greater interest to 
patients than indicated by its current utilization in clinical practice. One limitation in the Tarrier et 
al. study, however, was the exclusion of a medication comparison. Thus, none of the studies 
listed above offered participants a range of psychotherapy options along with a medication 
option – a choice which theoretically should be available to patients in clinical settings.  
A second potential limitation of Tarrier et al. is the extensive focus on variants of 
cognitive behavioral therapy (CBT). For example, depending on how one classifies EMDR, 
either 10 or 11 of the treatment options appear to be variants of CBT. In addition, over 50% of 
the interventions included exposure in some form or another. This is potentially problematic for 
two reasons. First, exposure may have been more highly rated because participants were 
influenced by its frequent appearance in the treatment descriptions. Second, although the 
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inclusion of many forms of CBT makes sense given that a) Tarrier et al. based their selection of 
treatments on the scientific PTSD treatment literature and b) CBT dominates this literature, it is 
unclear whether the scientific literature matches the range of treatment options to which 
individuals with PTSD may be exposed. For example, the internet often serves as a source of 
information for individuals with psychological disorders. During a quick internet search of “PTSD 
treatment,” we found a website promoting “promising” PTSD treatments. These approaches 
consisted of a series of interventions that have been labeled the “power therapies” (see Devilly, 
2005 for in depth discussion). Power therapies consist of interventions that typically rest on 
questionable theories and are associated with extensive and unsupported reports of 
extraordinary success rates and rapid effects (Devilly). With the exception of EMDR, which has 
received empirical scrutiny and support (Rothbaum, Astin, & Marsteller, 2005), most power 
therapies have not been subjected to rigorous scientific examination. Power therapies represent 
a concerning treatment option because their impressive, yet largely unsupported, claims may be 
attractive to traumatized individuals and lure them away from treatment with greater empirical 
support.  
The purpose of the present study was threefold. First, we sought to extend and combine 
the analogue approaches of Zoellner et al. (2003) and Tarrier et al. (2006) by including both a 
range of psychological interventions for PTSD and a medication option. Second, we sought to 
include some potentially troublesome interventions (i.e., power therapies) that traumatized 
individuals might encounter. Tarrier et al. included one power therapy, EMDR, in their study. 
Among the power therapies, however, EMDR has the greatest amount of empirical support and 
claims regarding its efficacy largely have been scaled back over time (Devilly, 2005). Therefore, 
in addition to EMDR, we selected a power therapy, Thought Field Therapy (TFT), with strong 
claims that are supported by substantially less empirical evidence (see McNally, 2001 for review 
of TFT). To further explore the degree to which analogue PTSD patients might be drawn to 
interventions lacking solid scientific foundations, we also developed our own intervention for 
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PTSD, which we based on real therapy product. The description of this fabricated intervention 
was designed to make an intentionally absurd treatment, which in essence proposed that a blue 
stuffed creature could be used to treat PTSD, sound psychologically viable.  
In a recent study, Sharp and Herbert (2006) found that professional psychologists who 
used techniques drawn from power therapies scored lower on a measure of critical thinking 
skills compared to psychologists who relied to a greater degree on techniques drawn from 
ESTs. Thus, the third goal of this study was to conduct a preliminary exploratory investigation as 
to whether or not critical thinking skills were similarly associated with treatment choice in 
analogue patients.  
Although exposure was highly rated in the Zoellner et al. (2003), Feeny and Zoellner 
(2004), and Tarrier et al. (2006) studies, we hypothesized that exposure would not be highly 
chosen when a greater number of non-CBT psychotherapy options were offered in addition to a 
medication option. This hypothesis was based, in large part, on the low-utilization of exposure in 
clinical practice. In addition, based on Sharp and Herbert’s (2006) study, we hypothesized that 
individuals who chose empirically supported treatments (e.g., exposure) over other therapies 
with less empirical support would evidence better critical thinking skills.   
1.2 Method 
1.2.1 Participants 
 One hundred and sixty students recruited from the psychology human subject pool at a 
small university participated in this study. The study was approved by the Trinity University 
Institutional Review Board, and students received course credit for their participation. Thirty-
eight percent of participants were male and sixty-two percent of participants were female; 
participants had an average age of 18.64 (SD = .73).  
1.2.2 Materials  
 1.2.2.1 Treatment Descriptions. Treatment descriptions outlined background information 
along with procedures, typical duration, efficacy information, and possible side effects for each 
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of seven treatments. The selected treatment options were designed to offer participants a 
choice of interventions that varied both in terms of orientation (e.g., CBT, psychodynamic, 
pharmacologic) and empirical support, so as to better represent the treatment options that 
individuals with PTSD may face both in clinical settings and when conducting their own research 
on the internet. We included one form of CBT that is strongly supported by the literature (i.e., 
exposure) and a pharmacological treatment also supported by research (i.e., sertraline). In 
addition, because many CBT therapists blend theoretical and practical elements from different 
types of CBT (Persons, 2005), we offered participants a more mixed CBT intervention that drew 
heavily from Cognitive Processing Therapy (Resick & Schnicke, 1992), yet also relied on some 
of the theory that often is used to support other forms of CBT for PTSD (Foa & Kozak, 1986).  
Next, we included two forms of psychotherapy that appear popular among therapists 
despite having less empirical support than exposure and other variants of CBT (i.e., EMDR and 
psychodynamic psychotherapy). Finally, we included a power therapy with relatively little 
empirical support (i.e., TFT), along with our intentionally absurd made-up therapy which we 
based on an existing therapy product (i.e., My Therapy Buddy (MTB)). Treatment descriptions 
from Zoellner et al.’s (2003) study were used for sertraline and exposure to facilitate comparison 
of results. We generated the remaining treatment descriptions for this study. Descriptions were 
designed to match those for sertraline and exposure in terms of length and style. We based 
treatment information, including efficacy descriptions, on existing literature for each therapy. If 
no significant scientific literature existed regarding the efficacy of a particular treatment (e.g., for 
TFT or MTB), we used a statement such as “the results of this treatment speak for themselves,” 
which is common claim of power therapies when marketed to lay audiences (e.g., see 
www.ritacanhelp.com/newsletter/12-96.html). The treatment description for MTB was closely 
based on clinical information provided at the website selling this product 
(www.mytherapybuddy.com), but differed in that we proposed that MTB could be used as the 
sole treatment for PTSD, a claim which is not made by the sellers of this product.  
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We constructed treatment descriptions to reflect actual information that might be 
presented to an individual who is seeking treatment for PTSD. The psychodynamic, EMDR, and 
CBT treatment descriptions were given to colleagues who use these therapies for critique. 
Because the sertraline and exposure descriptions were based on Zoellner et al. (2004), these 
were not sent out for review. We also did not send the TFT description for review because we 
did not have a TFT colleague with whom we could consult. As noted above, MTB was based on 
the description of the treatment provided on the associated website. Several faculty members in 
the psychology department, however, were asked to review the MTB description to judge 
whether the description sounded psychologically viable given what the treatment actually 
proposed; these colleagues also provided feedback on the TFT description. We sought to frame 
all therapies as viable treatment options, and all treatment descriptions were approximately of 
similar length, between 216 (EMDR) to 238 (MTB) words. See Appendix A for detailed 
treatment descriptions along with word counts.  
1.2.2.2 Measures. Two scales assessed participants’ opinions of each treatment: the 
Credibility Scale (CS; Addis & Carpenter, 1999) and Personal Reactions to the Rationale (PRR; 
Addis & Carpenter, 1999). The former scale assesses the degree to which participants find 
different treatment descriptions credible. The PRR, in contrast, assesses more personal 
reactions (i.e., does the individual think the treatment would work for him/her). Internal 
consistency for the PRR was good with alpha coefficients ranging from a low of .81 for exposure 
to a high of .95 for psychodynamic therapy in the present sample. We found similar results for 
the CS (α range = .85 (exposure) - .94 (psychodynamic therapy)).  
Participants also indicated their two most and two least preferred treatments from the 
seven options. We chose to not have participants rank all treatment options because 
participants likely have stronger opinions about treatments they most and least want, versus 
those that fall in the middle. Thus, we did not want to over-interpret middle ranking positions.   
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A Critical Thinking Questionnaire (CTQ: Sharp & Herbert, 2006) evaluated participants’ 
critical thinking skills. The CTQ was created by combining items from two established critical 
thinking measures (Ennis, Millman, & Tomko, 1985; Watson & Glaser, 1994) and another critical 
thinking source (Stanovich, 2001). Sharp and Herbert developed the CTQ to better target critical 
thinking skills relevant to psychology. Internal consistency in the present sample for this 
measure (α = .65) was somewhat lower than the internal consistency for the other measures.  
We assessed psychopathology using the following self-report measures: the 
Posttraumatic Stress Diagnostic Scale (PDS; Foa, Cashman, Jaycox & Perry, 1997), Beck 
Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996), and State-Trait Anxiety Inventory 
(STAI; Spielberger, Gorsuch, &Lushene, 1970). The PDS has satisfactory diagnostic agreement 
with interview measures of PTSD (Foa et al., 1997), and it demonstrated good internal 
consistency in the present sample (α = .89 for total symptom severity), as did the STAI (state α 
= .92; trait α = .87) and the BDI (α = .90). 
1.2.3 Procedure 
 After a brief introduction to the study, participants completed informed consent forms, 
and then received a copy of the following trauma scenario:  
Six months ago you went on a trip to New York City. After a show you decide to walk 
back to your hotel. On the way back, you were held up by a man with a knife in a secluded area 
on the street. He demanded your money, watch, and personal belongings and threatened that if 
you would not comply immediately, he would kill you. You gave him all that he asked, but he 
was not satisfied. He then began to beat and stab you violently. The next thing you knew, you 
woke up in a hospital after enduring several major surgeries. Since the incident, you have been 
experiencing difficulty sleeping and intrusive flashbacks where you feel as though you are back 
in that situation. Any time that you are invited out at night you typically refuse because you are 
afraid it might happen again. Also, you feel that you can’t talk to your friends about what 
happened because they won’t understand. In addition, you have felt more on edge lately and 
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are easily startled. Because your relationships and school work have suffered significantly, you 
decide to seek treatment at a counseling center for your symptoms. At the counseling center 
you are diagnosed with Post Traumatic Stress Disorder (PTSD). You now have a variety of 
options in terms of treatment.  Referral will depend on which treatment most interests you.  
An experimenter asked participants to imagine themselves in this situation and then read 
the scenario aloud to the participant. Participants then read treatment descriptions, which were 
given to them in random order, and completed CS and PRR forms for each therapy immediately 
after reading its description. After reading and evaluating all seven therapies, participants 
ranked their first and second most and their two least preferred choices for referral. Participants 
then completed the CTQ, followed by the BDI-II, STAI, and PDS.   Participants were then 
debriefed and thanked for their participation. 
1.3 Results  
1.3.1 PTSD Diagnoses and Trauma Histories of Participants 
 Eleven participants (7%) met DSM-IV criteria for PTSD as assessed by the PDS (Foa et 
al., 1997).  An additional 58 students (36%) reported experiencing a Criterion A traumatic event 
during their lifetime, but did not currently meet criteria for PTSD. Primary Criterion A events 
included motor vehicle accidents (24.6%), sexual assault (14.5%), physical assault (14.5%), 
witnessing a severe motor vehicle accident, death, or assault (14.5%), natural disasters (7.2%), 
terrorism, bombings, or fires (5.8%), suicide (1.4%), and other traumas (17.3%). 
1.3.2 Most and Least Preferred Two Treatment Choices 
 Treatments were not selected equally as the number one choice by participants 2 (N 
=160) = 163.40, p <.0001. Contrary to our hypothesis, exposure was the most preferred 
therapy, with 51% of the sample selecting it. CBT (22%) was the second most preferred 
therapy. The remaining therapies were chosen in the following order: psychodynamic therapy, 
sertraline, TFT, and MTB (see Table 1). No participant selected EMDR as his/her number one 
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choice. The rank order of the therapies remained unchanged when the top two choices were 
combined, although the magnitude of difference between exposure and CBT decreased.  
 To examine the role of trauma history and likely PTSD diagnosis on treatment choice, 
we examined treatment choice among participants with a trauma history and those who met 
PTSD criteria based on the PDS. Of the 69 participants who met criteria for a Criterion A event 
(note: this sub-sample includes participants who met criteria for PTSD), 51% again ranked 
exposure as their top therapy choice.  Compared to the overall sample, the rank ordering and 
percentage of participants selecting each therapy was largely unchanged (see Table 1).  
Eleven participants met criteria for PTSD. Exposure (36%) and CBT (27%) were again 
the most preferred therapy choices, with the remainder of participants selecting sertraline and 
psychodynamic therapy equally. The only time in which the rank ordering of the selections 
changed occurred when we examined the top two therapy choices of individuals with likely 
PTSD. Under this circumstance, participants most frequently selected CBT, followed by 
exposure and psychodynamic therapy (selected equally), and sertraline (see Table 1).  
 Regarding the participants least preferred therapy choice, we again found that therapies 
were not selected equally, 2 (N =160) = 87.69, p <.001. MTB was the most frequently selected 
least preferred therapy choice (47%). EMDR, TFT and sertraline were endorsed at virtually 
identical rates with between 17% and 18% of participants ranking these interventions as their 
least preferred intervention. No participant selected exposure or CBT as their least preferred 
treatment choice; when least and second least choices were combined only a small percentage 
of participants selected exposure (1%), CBT (1%), or psychodynamic psychotherapy (3%).  
1.3.3 Treatment Rationale 
Mean ratings and standard deviations for the PRR and the CS for each type of treatment 
are displayed in Table 2. For both scales, the three most highly rated interventions were 
exposure, CBT, and psychodynamic psychotherapy. MTB and EMDR were the lowest rated 
interventions for both scales. To investigate the degree to which participants rated the treatment 
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rationales as equal in terms of positive personal reactions and credibility, we conducted two 
within subject repeated measures analysis of variance (ANOVA) using PRR and CS scores as 
the dependent variables. Because our hypotheses centered largely on exposure and because 
paired comparisons between each intervention would have resulted in 21 follow-up tests for 
each measure, we limited post-hoc comparisons to simple contrasts between exposure and the 
remaining treatments. For the PRR, there was a significant within subjects effect, F (6, 954) = 
240.05, p = .0001, partial 2 = .60, indicating that participants rated the interventions differently 
in terms of their personal positive reactions. Simple contrasts indicated that participants rated 
exposure more highly than each of the other treatments. For the CS, we again found a 
significant effect for treatment type, F (6, 924) = 177.66, p = .0001, partial 2 = .54, and simple 
contrasts indicated that exposure was rated as more credible than each of the other 
interventions. 
Analyses of PRR and CS scores in participants who reported a Criterion A event and 
those who met self-report criteria for PTSD indicated an identical pattern as described above 
with one exception. In the sample of participants who met criteria for PTSD (n = 11), the follow-
up contrast analyses indicated no significant difference between exposure and CBT or exposure 
and psychodynamic therapy on either the PRR or CS. It should be noted, however, that the lack 
of significance appears to mostly be related to sample size. More specifically, the effect size of 
the difference between PR ratings for exposure and PR ratings for CBT were virtually identical 
in all three samples (total sample d = .68; Criterion A sample d = .74; PTSD sample d = .68). 
1.3.4 Critical Thinking Scores 
 To examine the relationship between critical thinking and treatment choice, we recoded 
patients based on their two most preferred therapies. Because it is hard to argue that 
participants who choose exposure as their first therapy choice and CBT as their second should 
meaningfully differ with respect to critical thinking compared to participants who choose CBT 
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first and exposure second, we divided participants into two groups. Group 1 (n = 84) consisted 
of participants who selected exposure, CBT, and/or sertraline for both of their top two choices. 
These three treatments were described as having the most empirical support, which is the 
reason we chose to cluster them. 
We had planned on comparing Group 1 to participants who exclusively chose 
interventions with limited empirical support (e.g., TFT, MTB) and to a group that chose a mix of 
interventions. This was not possible, however, because review of participant choices indicated 
that all participants selected at least one of the three most empirically supported treatment 
options (i.e., exposure, CBT, and Sertraline) as their first or second choice. As noted above, no 
participant selected EMDR for either their first or second choice. Thus second group (n = 76) 
comprised of participants who chose one of the three treatments in Group 1 along with 
psychodynamic treatment, TFT, or MTB.   
As noted above, we hypothesized that participants who chose empirically supported 
interventions would evidence greater critical thinking skills than those who did not. Because 
both groups selected empirically supported interventions to some degree, we were unable to 
submit this hypothesis to as robust a test as we would have preferred (i.e., compare participants 
who chose no empirically supported interventions to those who did). Nonetheless, results of a 
one-tailed t-test provided some support for our hypothesis. Participants in Group 1 had a higher 
mean CTQ score (M = 18.82, SD = 3.03) compared to participants in Group 2 (M = 17.89, SD = 
3.76), t (157) = 1.73, p = .04, Cohen’s d = .27.  
1.3.5 Relationship between depression / anxiety and credibility / personal reaction scores 
 In order to facilitate comparison with the study by Zoellner et al. (2004), we correlated 
BDI, state and trait anxiety scores with the CS and PRR scores. Using a Bonferroni correction 
(p < .001), we found that trait anxiety was associated with higher positive personal reactions to 
psychodynamic therapy (r = .28) and higher credibility scores (r = .27). No other correlations 
approached significance. 
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1.4 Discussion 
 The present study replicates findings from previous studies (i.e., Zoellner et al., 2003; 
Feeny & Zoellner, 2004; Tarrier et al., 2006) and suggests that patients may be more receptive 
to exposure for PTSD than indicated by current clinical practice utilization rates. Contrary to our 
hypothesis, exposure remained the most preferred treatment choice even when participants had 
the option of selecting more traditional psychotherapy (i.e., psychodynamic therapy), power 
therapies, and medication. This finding also held when we examined participants who had 
experienced a traumatic event. Although the percentage of participants ranking exposure as 
their first choice treatment decreased somewhat when we only examined participants who met 
self-report criteria for PTSD (from 51% to 36%), exposure still remained the most selected first 
therapy choice. Furthermore, over 50% of this sub-sample selected it as one of their two most 
preferred treatment options.  Although the small sample size of the PTSD group limits the 
conclusions that can be drawn, the consistency of results, both within this study and across the 
three previous studies mentioned above, supports the interpretation that exposure may be 
significantly more acceptable to patients than many therapists expect. Furthermore, the fact that 
studies conducted in both the United States and United Kingdom, which have different health 
care systems and means of paying for psychological services, have produced similar results 
also suggests that results may point to the acceptability of exposure. Given that three of the 
studies (including this one) have used analogue samples, however, further research is needed 
with patient samples. This is particularly the case because one factor that may differentiate 
those who develop PTSD from those who do not is a propensity for avoidance (Keane & Barlow, 
2002). Individuals who are more inclined to use avoidance as a coping strategy may be 
somewhat less inclined to pursue exposure secondary to their avoidant tendencies.  Indeed, the 
fact that our small sample of participants with PTSD showed a slight decrease in preference for 
exposure compared to the total sample supports this concern. In addition, this sub sample 
showed an increased interest in sertraline as a first choice treatment (19% compared to 9% for 
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the total sample), an increase that mirrors that found by Zoellner et al. (22% in PTSD 
subsample compared to 7% in total sample).  
 Results from the PRR and CS basically mirrored those for treatment choice. Participants 
rated exposure as the most credible treatment and it also was associated with the most positive 
personal reactions. These results held even when we only examined data from participants who 
had experienced a traumatic event or participants who met criteria for PTSD.  
 Also consistent with the study by Tarrier et al. (2006), participants in the present study 
showed considerable interest in CBT with a stronger cognitive restructuring focus, and a 
surprising lack of interest in EMDR. Regarding participants’ ranking of CBT generally, exposure 
and the cognitive restructuring intervention were the most consistently selected preferred 
therapy choices. Tarrier et al. similarly found that four of the five most highly ranked treatments 
were variants of cognitive restructuring and/or exposure and that the highest ranked treatment 
was cognitive therapy. Results from both studies indicate that patients may find empirically 
supported cognitive behavioral therapies for PTSD generally acceptable. Given the analogue 
nature of these studies and the fact that exposure and cognitive therapy were highly rated in 
both studies, we do not believe that the findings from these studies suggest a clear preference 
for cognitive therapy over exposure or vice versa.  
 As noted above, participants showed little interest in EMDR. In fact, EMDR was the only 
therapy not chosen by a single participant as either a first or second choice. This is interesting 
for several reasons. First, although participants in this study showed little interest in EMDR, 
EMDR appears to be a relatively popular treatment modality among clinicians (e.g., there is an 
international association, conference, and journal devoted to EMDR). The lack of 
correspondence between respondents in the present study and clinician interest in EMDR 
suggests that, as with exposure, there may be a disconnection between patient and clinician 
attitudes about PTSD interventions. Second, although it would be easy to dismiss this result as 
a random finding, Tarrier et al. (2006) found that EMDR was the second lowest ranked therapy 
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in their study. Thus, despite using different EMDR descriptions, both studies generated similar 
results. Third, it could be argued that results for EMDR might indicate experimenter bias. Indeed 
we fully admit that we have a preference for exposure and the other CBT intervention over 
EMDR. We also, however, prefer the empirical support backing EMDR compared to that 
available for psychodynamic therapy, TFT or MTB. Thus, our bias should have generated 
rankings in which EMDR was preferred over those treatments. This was not, however, what we 
found. Finally, although we attempted to keep the word counts similar, they were slightly 
different for the different treatment descriptions. Thus, it could be argued that word count 
influenced the decreased interest in EMDR given that it was associated with the lowest word 
count. However, MTB was the second least preferred treatment, and was associated with the 
highest word count. Furthermore, results from Tarrier et al. indicated that word length was not 
associated with the acceptability of treatment. Thus, it seems unlikely that word count played a 
significant role. In sum, we suggest that the EMDR finding, like that for exposure, may indicate a 
potential real difference between therapist and patient perceptions about these therapies.  
 If the results of the four studies investigating patient (or analogue patient) attitudes to 
PTSD treatments are correct in pointing to a possible misalignment of the PTSD treatments that 
therapists are drawn towards and those that patients prefer, then it will be important to identify 
why this is the case. For example, it may be that empirical support and a logical rationale 
matters more to patients, who are looking for relief. Results from Tarrier et al. (2006) also 
suggest that patients may be willing to endure anticipated discomfort if they believe that the 
treatment will help them. In contrast, some therapists may shy away from therapies that they 
perceive as requiring them to increase distress in patients, even if such interventions are 
supported by both a logical rationale and data. For example, it appears that some therapists find 
exposure unpalatable, regardless of the data that support the intervention. Rather, therapists 
appear to have problems with the likelihood of producing discomfort in patients, possibly in the 
form of exacerbated symptoms. More specifically, personal communications sent to this lab 
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after the publication of the Becker et al. (2004) study indicate that some therapists believe that 
straightforward exposure is “mean”; this perception is further supported by a popular press 
article that labeled exposure as the “cruelest cure” and cited “one clinician” as saying that 
exposure is “torture, plain and simple” (Slater, 2003). Thus, it may be fruitful to begin 
researching strategies for changing therapist attitudes about exposure.  
 One novel exploratory aspect of the present study was the inclusion of a measure of 
critical thinking skills. As noted above, Sharp and Herbert (2006) found that therapist critical 
thinking skills were associated with greater use of EST techniques. The present study found that 
patients who showed a greater interest in evidence based treatment, as indicated by choosing 
ESTs for both top therapy choices, scored higher on a measure of critical thinking as compared 
to those who chose a mix of empirically supported and alternate treatments. These studies 
represent a preliminary inquiry into the role that critical thinking skills may play in therapy 
preferences, particularly a preference for ESTs. As noted by Gambrill (2005), critical thinking is 
associated with both scientific reasoning and evidence based practice. Thus, emerging findings 
suggesting that ability to think critically may be associated with a preference for empirically 
supported techniques should, perhaps, come as no surprise. Nonetheless, given the difficulties 
encountered in disseminating ESTs into routine clinical practice, we suggest that it is important 
to better understand all of the factors that may influence therapy preferences, both from the 
perspective of a therapist and of a patient.  
 We were pleased to see relatively low interest in our intentionally absurd therapy, MTB. 
We also were pleased by the fairly low interest in TFT, even though the use of TFT appears to 
be alive and well in clinical practice. Two factors may account for this discrepancy. First, we 
could be observing a problem with sample bias in this study given that all participants were 
enrolled in a competitive university, which might elevate critical thinking skills generally and lead 
to decreased interest in TFT. One argument against this explanation is the fact that the 
participants’ CTQ scores ranged from 8 to 27, indicating marked variability in critical thinking 
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skills.  Alternatively, it may be that patients buy into TFT when it is sold to them by an invested 
therapist, but might not select TFT if they were provided with a comprehensive set of treatment 
options. This explanation would, once again, suggest that the underutilization of ESTs such as 
exposure may be primarily driven by therapists not patients.  
 This study has a number of limitations, not the least of which is the use of an analogue 
sample. It can be argued that results from an analogue sample may not generalize to clinical 
populations; indeed, this is the reason that we encourage extension of this research with clinical 
populations. It also should be noted, however, that results from Zoellner et al. (2003) did largely 
generalize when the study was repeated with a clinical sample (Feeny & Zoellner, 2004). In 
addition, results in this study were fairly consistent even when we examined sub-samples that 
may be more similar to clinical populations. A second limitation relates to the actual treatment 
descriptions. It could be argued that descriptions that included more detail about the level of 
scientific support were stronger and, thus, that the study was biased. Theoretically, however, 
patients in clinical practice should be accurately informed about the level of scientific support for 
alternate treatments as part of informed consent. Thus, it did not appear to be accurate nor 
make sense to claim that un-tested treatments had extensive empirical support.   
 In summary, the present study adds to a growing body of research suggesting that 
exposure for PTSD may be an acceptable treatment option to many patients when they are 
presented with a range of treatment choices and accurate information about the evidence 
supporting the different interventions. The results from this study and previous research further 
suggest that there may be a disconnection between treatments that appeal to therapists and 
those that patients select. Future research is needed to better understand therapist attitudes 
about exposure for PTSD given that therapists, not patients, may be a driving force behind 
underutilization of this treatment in clinical practice. 
 
 20
 
1.5 References 
Addis, M. E., & carpenter, K. M. (1999). Why, why, why?: Reason giving and rumination as 
predictors of response to activation- and insight oriented treatment rationales. Journal of 
Clinical Psychology, 55(7), 881-894 
Beck, A. T., Steer, R. A., Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. San 
Antonio, TX: Psychological Corporation. 
Becker, C. B., Zayfert, C., & Anderson, E. (2004). A survey of psychologists' attitudes towards 
and utilization of exposure therapy for PTSD. Behaviour Research & Therapy, 42, 277-
292. 
Devilly, G. J. (2005). Power Therapies and possible threats to the science of psychology and 
psychiatry.  Australian and New Zealand Journal of Psychiatry, 39(6), 437-445. 
Ennis, R. H., Millman, J., & Tomko, T. N. (1985). Cornell Critical Thinking Tests Level X & Level 
Z Manual, 3rd Ed. Pacific Grove, CA: Critical Thinking Books and Software. 
Feeny, N. C., & Zoellner, L. A. (November, 2004).  Prolonged exposure versus sertraline:  
Primary outcomes for the treatment of chronic PTSD.   Paper presented at the 
International Society for the Study of Traumatic Stress, New Orleans, LA. 
Foa, E. B., Cashman, L., Jaycox, L., & Perry, K. (1997). The validation of a self-report measure 
of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. Psychological 
Assessment, 9(4), 445-451. 
Foa, E. B., Keane, T. M., & Friedman, M. J. (Eds.). (2000). Practice guidelines from the 
international society for traumatic stress studies: Effective treatments for PTSD. New 
York: The Guilford Press. 
Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective 
information. Psychological Bulletin, 99(1), 20-35. 
 
 21
 
Foy, D. W., Kagan, B., McDermott, C., Leskin, G., Sipprelle, R. C., & Paz, G. (1996). Practical 
parameters in the use of flooding for treating chronic PTSD. Clinical Psychology and 
Psychotherapy, 3(3), 169-175. 
Gambrill, E. (2005). Critical thinking in clinical practice: Improving the quality of judgments and 
decisions (2nd Ed). Hoboken, NJ: John Wiley & Sons. 
Keane, T. M., & Barlow, D. H. (2002). Posttraumatic stress disorder. In D. H. Barlow (Ed.), 
Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). New 
York: Guilford. 
McNally, R. J. (2001). Tertullian's motto and Callahan's method. Journal of Clinical Psychology, 
57(10), 1171-1174. 
Najavits, L. M. (2006). Present- versus past-focused therapy for posttraumatic stress 
disorder/substance abuse: A study of clinician preferences. Brief Treatment and Crisis 
Intervention, 6(3), 248-254. 
Persons, J. B. (2005). Empiricism, mechanism, and the practice of cognitive-behavior therapy. 
Behavior Therapy, 36(2), 107-118. 
Resick, P. A., & Schnicke, M. K. (1992). Cognitive processing therapy for sexual assault victims. 
Journal of Consulting and Clinical Psychology, 60, 748-756. 
Rosen, C. S., Chow, H.S., Finney, J.F., Greenbaum, M.A., Moos, R.H., Javaid, I.S., Yesavage, 
J.A. (2004). VA practice patterns and practice guidelines for treating posttraumatic stress 
disorder. Journal of Traumatic Stress, 17, 213-222. 
Rothbaum, B. O., Astin, M. C., Marsteller, F. (2005). Prolonged exposure versus eye movement 
desensitization and reprocessing (EMDR) for PTSD rape victims. Journal of Traumatic 
Stress, 18, 607-616. 
Sharp, I. R., & Herbert, J. D. (2006). The role of critical thinking skills in practicing psychologists’ 
use of empirically supported vs. novel treatments. Manuscript in preparation. 
 22
Slater, L. (2003, November 2). Cruelest cure. New York Times Magazine, 34-37 
Spielberger, C. D., Gorsuch, R. L., & Lushene, R. J. (1970). Manual for the State-Trait Anxiety 
Inventory (Self-Evaluation Questionnaire). Palo Alto, CA: Consulting Psychologists 
Press. 
Stanovich, K. E., (2001). How to think straight about psychology (6th ed). New York, NY: 
HarperCollins Publishers. 
Tarrier, N., Liversidge, T., Gregg, L. (2006). The acceptability and preference for the 
psychological treatment of PTSD. Behaviour Research and Therapy, 44(11), 1643-1656. 
Watson, G., & Glaser, E. M. (1994). Watson-Glaser Critical Thinking Appraisal-Manual Form S. 
San Antonio, TX: Psychological Corporation. 
Zoellner, L. A., Feeny, N. C., Cochran, B., & Pruitt, L. (2003). Treatment choice for PTSD. 
Behaviour Research & Therapy, 41, 879-886. 
 23
 
Acknowledgments:  We are grateful to Frank Robinson for his assistance in running this study 
and to the reviewers for their helpful feedback. 
 
Parts of this manuscript were presented at the 40th Annual Meeting of the Association for 
Behavioral and Cognitive Therapies, Chicago, IL  
 24
 
 
 
Table 1. Percent of participants who chose each therapy option as most or second most 
preferred 
 
Note: Criterion A = all participants reporting lifetime occurrence of a criterion A event. PTSD = 
all participants meeting full criteria for PTSD. CBT = Cognitive Behavioral Therapy. EMDR = 
Eye Movement Desensitization Reprocessing. TFT = Thought-Field Therapy. MTB = My 
Therapy Buddy. 
 
 Total Sample  
(N = 160) 
Criterion A 
(n = 69) 
PTSD 
(n = 11) 
 
 Top Choice 
(%) 
Top 2 
(%) 
 Top Choice 
(%) 
Top 2 
(%) 
 Top Choice 
(%) 
Top 2 
(%) 
Exposure 50.6 71.3 50.7 66.7 36.4 54.6 
CBT 21.9 58.1 17.4 53.6 27.3 63.6 
Psychodynamic 15.6 38.1 15.9 39.1 18.2 54.6 
Sertraline 8.8 23.8 11.6 24.6 18.2 27.3 
TFT 2.5 6.9 2.9 8.7 0.0 0.0 
MTB 0.6 1.9 1.4 4.3 0.0 0.0 
EMDR 0.0 0.0 0.0 0.0 0.0 0.0 
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Table 2. Mean, standard deviation, and range on credibility scales, personal reactions to the  
rationales, critical thinking questionnaires, and psychopathology measures 
 
Measure M SD Range 
 
PRR – Exposure 27.36 4.13 15-35 
 
PRR - CBT 23.85 6.04 7-35 
 
PRR - Psychodynamic 22.29 7.00 7-35 
 
PRR - Sertraline  15.54 5.77 5-31 
 
PRR - TFT 14.00 6.21 5-32 
 
PRR - EMDR 11.83 5.18 5-29 
 
PRR - MTB 10.89 5.29 5-29 
 
CS - Exposure 36.32 5.88 18-49 
 
CS - CBT 32.89 7.91 9-47 
 
CS – Psychodynamic 29.29 9.42 7-48 
 
CS – Sertraline 26.66 8.79 7-48 
 
CS – TFT 19.72 8.84 7-44 
 
CS – EMDR 16.47 6.85 7-42 
 
CS - MTB 16.19 7.75 7-37 
 
CTQ 18.38 3.41 8-27 
 
BDI-II 9.78 7.57 0-45 
 
STAI State 37.71 10.37 20-67 
 
STAI Trait 39.25 9.50 24-66 
 
PDS symptom severitya 6.45 6.82 0-32 
 
PDS diagnosis 6.88% N/A N/A 
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Note: N = 160. a Symptom severity is calculated for those reporting a Criterion A event (n = 69). 
CBT = cognitive behavioral therapy. EMDR = eye movement desensitization reprocessing. TFT 
= thought-field therapy. MTB = my therapy buddy. CS = Credibility Scale. PRR = Personal 
Reactions to the Rationale. CTQ = Critical Thinking Questionnaire. BDI-II = Beck Depression 
Inventory – II, STAI = State-Trait Anxiety Inventory. PDS = Posttraumatic Diagnostic Scale.  
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Appendix A 
Prolonged Exposure (227 Words) 
 Prolonged Exposure (PE) is a 9-12 session individual therapy that has been shown to be 
effective in the treatment of PTSD.  Of the available psychotherapies used for PTSD, PE has 
undergone some of the most rigorous scientific evaluation; results of several controlled studies 
have shown it to significantly reduce PTSD symptoms, particularly in women. PE is a type of 
cognitive behavioral treatment, which is designed to specifically target a number of trauma-
related difficulties. 
 If you choose this treatment for PTSD, you will meet once a week with your therapist for 
60-90 minutes. You will not receive medication for your PTSD symptoms. Procedures in this 
treatment include: education about common reactions to trauma, breathing retraining (relaxation 
training), prolonged (repeated) exposure to trauma memories, repeated in vivo (i.e., in real life) 
exposure to situations that you are avoiding due to trauma-related fear. In other words, you will 
be encouraged to confront the memory of your trauma through repeatedly telling the story to 
your therapist and to confront things in your life that you are avoiding because they make you 
afraid (e.g., driving a car, walking on the street at night).  In this program, you will be assigned 
“homework” to encourage you to practice in life the things you learn in therapy.  
 The risks associated with PE are mild to moderate discomfort when exposed to anxiety-
provoking images, situations, and places. 
 
Cognitive Behavioral Therapy (225 Words) 
Cognitive behavioral therapy (CBT) is a treatment package developed for PTSD. CBT 
can be conducted in individual or group format and is completed in 12 sessions. CBT has 
undergone rigorous scientific evaluation and has been supported by clinical trials.  An 
assumption of CBT states that information about trauma is stored in ‘fear networks’ in the brain. 
This network’s purpose is to stimulate future avoidance to prevent another experience of 
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trauma; however, this network may be overactive and overly general in people experiencing 
PTSD. Negative self statements perpetuate these ‘fear networks’. The goal of CBT is to process 
emotions and confront beliefs about the trauma and its implications for present-day living.  
If you choose CBT, you will complete weekly 90-minute individual therapy sessions.  
You will not receive medication for your PTSD symptoms.  You will be asked to write detailed 
narratives of the traumatic event and will read the narratives aloud in session and for homework. 
You will be provided basic education about feelings, given information about how self-
statements affect emotions, and are encouraged to identify ‘stuck points’ (improperly processed 
emotions about the trauma) in your narrative and challenge improper beliefs about the trauma 
such as self blame.  By doing this, you will find and maintain a balanced, realistic perception of 
the world. 
 Side effects of CBT include uncomfortable feelings and unsettling thoughts when 
remembering the trauma.   
 
Pharmological treatment – Zoloft (218 Words) 
 Zoloft (Setraline) is an antidepressant that has been shown to be effective in the 
treatment of PTSD. Of the available medications used for PTSD, Zoloft has undergone some of 
the most rigorous scientific evaluation; it is the only FDA approved medication for the treatment 
of PTSD. Zoloft is a type of antidepressant called an SSRI, or, selective serotonin reuptake 
inhibitor, which is designed to have fewer side effects than older antidepressants (e.g., MAOIs, 
TCAs, SRIs).  
 If you choose this treatment for PTSD, you will take up to 200 mg of Zoloft daily for 10 
weeks. In this treatment you will not talk extensively about your traumatic experience or be 
encouraged to confront situations or places you are avoiding. You will be seen weekly by a 
psychiatrist who will offer general encouragement and support, monitor your response to 
medication, and record any side effects you are experiencing. Your medication will be adjusted 
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according to a dosing schedule or as clinically indicated. At the end of 10 weeks, the medication 
will be tapered (reduced) gradually to minimize the chance of withdrawal symptoms with 
medication discontinuation.  
 The risks associated with Zoloft are mild to moderate side effects or withdrawal 
symptoms. Possible side-effects include loose stools, sweating, nausea, headache, fatigue, 
anorexia, weight loss or gain, sexual impairment, increased anxiety, restlessness, and 
insomnia.  
 
Eye Movement Desensitization and Reprocessing (216 Words) 
Eye Movement Desensitization and Reprocessing (EMDR) is a complex form of 
psychotherapy that borrows elements from other forms of therapy.  Some research supports the 
use of EMDR. EMDR proposes that focusing on external stimuli- such as a moving visual object 
- promotes the processing of internal stimuli, such as traumatic memories.  External stimuli may 
include bilateral hand tapping or having your therapist move his\her finger back and forth in front 
of your eyes.   
 If you choose EMDR, you will meet with a therapist for several sessions.  Often the 
number of sessions is quite limited. You will not receive medication for your PTSD symptoms. 
You will identify the most vivid memory of your trauma and a negative belief.  You will then 
focus on the memory image while moving your eyes back and forth and following the therapist's 
fingers. You will also need to monitor your body’s sensations. You will then be instructed to let 
your mind wander and or go blank.  You will then catalogue your minds activities. Your therapist 
will then help you identify the next therapy target.  You will also work on increasing positive 
beliefs.   
EMDR has generally been associated with positive outcomes, and may sometimes be 
used in combination with other therapies. Risks include mental distress which can cause 
adverse arousal of the body. 
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Psychodynamic Therapy (230 Words) 
Psychodynamic therapy has been used for over a century to treat traumatic symptoms. 
The goal of psychodynamic therapy is to make sense of the context of your trauma, and to 
make sense of defensive psychic processes that allow the unconscious to transform repressed 
memories into pathological symptoms. Psychodynamic therapy generally has not been 
rigorously evaluated in research trials because treatment tends to focus on psychic processes 
as opposed to psychological symptoms.  
If you chose psychodynamic psychotherapy you will meet individually with a therapist 
who will help you work through the underlying issues so that you are able to understand the 
meaning of your unconscious processes. You will not receive treatment for your PTSD 
symptoms.  The therapeutic relationship is a critical component of therapy, and this relationship 
will help you learn how to manage with your intense emotions. You also will work to achieve a 
balance between your subjective needs, the external demands of the world, and your traumatic 
memories. Your therapist generally will maintain a neutral stance during therapy. In other words, 
your therapist will not give you advice regarding what to do. Rather you will explore your 
feelings and behaviors so that you can gain insight regarding your symptoms, which will 
increase your awareness and allow you to better control your symptoms. Treatment may be 
long term. 
Side effects of psychodynamic psychotherapy may include uncomfortable feelings and 
unsettling thoughts.  
 
Thought-Field Therapy (226 Words) 
Thought –Field therapy (TFT) is a treatment requiring only one, short session of therapy.  
Thought-field therapy treats many conditions including PTSD, phobias, anxiety, depression, 
arthritis pain, and insomnia. Although TFT has undergone few clinical trials, many people 
maintain that the results seen in TFT speak for themselves. TFT states that acupressure points 
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mediate energy flow in the body, and treatment using this approach focuses on balancing the 
body’s energy system through reprocessing of memories while tapping the body’s meridians.   
If you choose thought field therapy, you will meet once with a therapist for 20 minutes. 
You will not receive medication for your PTSD symptoms. The session will begin by asking you 
to concentrate on the specific trauma associated with your distress. You will then rate the 
severity of distress, and, based on this rating, the therapist will ask you to tap your fingers on a 
specific meridian point.  A focusing of attention to the trauma will then allow a release of energy 
through the previously blocked meridian.  Results are seen immediately in relation to the 
trauma’s ‘thought-field’. You will be asked to rate your distress throughout the session in order 
to see results as they happen.  
Few side effects of TFT have been documented other than initial discomfort in 
remembering the traumatic event, and successful thought-field treatment has even been 
correlated with improved heart rate variability. 
 
My Therapy Buddy (238 Words) 
 My Therapy Buddy (MTB), a carefully researched transitional object, was designed to 
facilitate the internalization of your maternal relationship. Use of MTB builds critical and long 
lasting psychic structures which soothe you and overcome your traumatic experience.  MTB is 
based on the Winnicottian notion of the universal need for a transitional object.  Research has 
shown that transitional objects, such as MTB, significantly reduce depression and anxiety.  MTB 
does this by acting as a midpoint between receiving comfort from others and the internalizing of 
maternal comfort.  Although MTB was not specifically designed to treat trauma, the benefits of 
MTB have been so apparent that they speak for themselves. Thus, the use of MTB has been 
extended to the treatment of trauma.  
 If you choose this treatment for PTSD, you will rely on MTB whenever you feel anxious 
or sad. You will not receive any medication for your PTSD symptoms.  The motto of MTB is 
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“everything is going to be alright.”  You will use MTB in the privacy of your own home whenever 
you need comfort and emotional support. By softly touching the left or right foot of MTB, you can 
access the supportive words that one desires in a time of need.  The gentle, huggable feel to 
MTB also provides critical physical comfort as well.  Through repeated use, MTB becomes a 
vital soothing component that will facilitate the healing process. 
 The risks associated with MTB are minimal to none. 
 
